NVDL:OTO-Novadel Pharma Inc (USD)

ETF | Others | OTC Pink

Last Closing

USD 47.31

Change

-11.08 (-18.98)%

Market Cap

USD 0.98M

Volume

0.04B

Analyst Target

USD 1.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NovaDel Pharma Inc. is a pharmaceutical Company, which develops oral spray formulations for a range of marketed pharmaceuticals.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-03 )

Largest Industry Peers for Others

ETFs Containing NVDL

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange (OTC Pink)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 216.81% 100% F 98% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 216.81% 100% F 98% N/A
Trailing 12 Months  
Capital Gain 181.13% 99% N/A 98% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 181.13% 99% N/A 98% N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 147.89% N/A N/A 96% N/A
Dividend Return 147.89% N/A N/A 96% N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 192.80% N/A N/A 9% A-
Risk Adjusted Return 76.70% N/A N/A 90% A-
Market Capitalization 0.98M 98% N/A 79% B-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Negative earnings

The company had negative total earnings in the most recent four quarters.